AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Geneglim-M2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Geneaid Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Geneglim-M2 Tablet ER

Diabexe Duo ER tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This dual-action formulation helps manage blood glucose levels. Diabexe Duo ER should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and have a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Geneglim-M2 Tablet ER

There is no text provided to rephrase.

Uses of Geneglim-M2 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Geneglim-M2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Geneglim-M2 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Geneglim-M2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Geneglim-M2 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Geneglim-M2 Tablet ER whole; avoid chewing, crushing, or breaking it. It should be administered with a meal.

How Geneglim-M2 Tablet ER works:

Geneglim-M2 Extended-Release tablets contain a dual-action formulation of glimepiride and metformin, both agents used to manage diabetes. Glimepiride, a sulfonylurea derivative, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts via a three-pronged mechanism: decreasing hepatic glucose output, impeding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Geneglim-M2 Tablet ER is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Geneglim-M2 tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Geneglim-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Geneglim-M2 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Geneglim-M2 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

The extended-release Geneglim-M2 Tablet requires careful consideration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiation with a reduced Geneglim-M2 Tablet ER dose is typical; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Geneglim-M2 Tablet ER :

Should you forget a Geneglim-M2 Tablet ER dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Geneglim-M2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Geneglim-M2 Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Geneglim-M2 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this risk is heightened in patients with kidney disease, older adults, and heavy alcohol consumers. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Geneglim-M2 Tablet ER and seek immediate medical attention.
Geneglim-M2 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Geneglim-M2 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Geneglim-M2 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Geneglim-M2 ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Geneglim-M2 Tablet ER and alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Geneglim-M2 Tablet ER
81
MRP 99
18% off